TBX1 and non-small cell lung carcinoma: Brachyury has been found to be overexpressed in various human carcinomas, both in the primary tumor and metastatic sites, including in non-small cell (NSCLC) and small cell (SCLC) lung cancer (6, 7), triple-negative breast (TNBC) cancer (8, 9), prostate (4), and colon cancer (10, 11), among others.